β-amyloid and neprilysin computational studies identify critical residues implicated in binding specificity

Journal of Chemical Information and Modeling

Volumn 54, Issue 4, 2014, Pages 1157-1165

  Pope, Darrick ^a   Madura, Jeffry D ^a   Cascio, Michael ^a  

^a DUQUESNE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEURODEGENERATIVE DISEASES; PEPTIDES; SUBSTRATES;

AMINO ACID INTERACTIONS; AMYLOID-BETA PEPTIDES; BINDING SPECIFICITIES; COMPUTATIONAL STUDIES; PROTEIN-LIGAND DOCKING; SPECIFIC INTERACTION; THERAPEUTIC POTENTIALS; ZINC METALLOPROTEASE;

GLYCOPROTEINS;

AMYLOID BETA PROTEIN; MEMBRANE METALLOENDOPEPTIDASE;

AMINO ACID SEQUENCE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; MOLECULAR GENETICS; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; AMYLOID BETA-PEPTIDES; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEPRILYSIN;

EID: 84899842987     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci500015m     Document Type: Article

References (75)

1. Turner, A. J.; Isaac, R. E.; Coates, D. The Neprilysin (NEP) Family of Zinc Metalloendopeptidases: Genomics and Function Bioessays 2001, 23, 261-269
2. Turner, A. J.; Tanzawa, K. Mammalian Membrane Metallopeptidases: NEP, ECE, KELL, and PEX FASEB J. 1997, 11, 355-364
3. Roques, B. P.; Noble, F.; Dauge, V.; Fournie-Zaluski, M. C.; Beaumont, A. Neutral Endopeptidase 24.11: Structure, Inhibition, and Experimental and Clinical Pharmacology Pharmacol. Rev. 1993, 45, 87-146
4. Miners, J. S.; van Helmond, Z.; Kehoe, P. G.; Love, S. Changes with Age in the Activities of Beta-Secretase and the a Beta-Degrading Enzymes Neprilysin, Insulin-Degrading Enzyme and Angiotensin-Converting Enzyme Brain Pathol. 2010, 20, 794-802
5. Wang, S. Q.; Wang, R.; Chen, L.; Bennett, D. A.; Dickson, D. W.; Wang, D. S. Expression and Functional Profiling of Neprilysin, Insulin-Degrading Enzyme, and Endothelin-Converting Enzyme in Prospectively Studied Elderly and Alzheimer's Brain J. Neurochem. 2010, 115, 47-57
6. Nalivaeva, N. N.; Fisk, L. R.; Belyaev, N. D.; Turner, A. J. Amyloid-Degrading Enzymes as Therapeutic Targets in Alzheimer's Disease Curr. Alzheimer. Res. 2008, 5, 212-224
7. Hardy, J.; Selkoe, D. J. Medicine-the Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics Science 2002, 297, 353-356
8. Mawuenyega, K. G.; Sigurdson, W.; Ovod, V.; Munsell, L.; Kasten, T.; Morris, J. C.; Yarasheski, K. E.; Bateman, R. J. Decreased Clearance of CNS Beta-Amyloid in Alzheimer's Disease Science 2010, 330, 1774
9. Miners, J. S.; Barua, N.; Kehoe, P. G.; Gill, S.; Love, S. Abeta-Degrading Enzymes: Potential for Treatment of Alzheimer Disease J. Neuropathol. Exp. Neurol. 2011, 70, 944-959
10. Ahmed, M.; Davis, J.; Aucoin, D.; Sato, T.; Ahuja, S.; Aimoto, S.; Elliott, J. I.; Van Nostrand, W. E.; Smith, S. O. Structural Conversion of Neurotoxic Amyloid-Beta(1-42) Oligomers to Fibrils Nat. Struct. Mol. Bio. 2010, 17, 561-567
11. Goedert, M.; Spillantini, M. G. A Century of Alzheimer's Disease Science 2006, 314, 777-781
12. Dahlgren, K. N.; Manelli, A. M.; Stine, W. B., Jr.; Baker, L. K.; Krafft, G. A.; LaDu, M. J. Oligomeric and Fibrillar Species of Amyloid-Beta Peptides Differentially Affect Neuronal Viability J. Biol. Chem. 2002, 277, 32046-32053
13. Maezawa, I.; Zimin, P.; Wulff, H.; Jin, L.-W. Amyloid-Beta Protein Oligomer at Low Nanomolar Concentrations Activates Microglia and Induces Microglial Neurotoxicity J. Biol. Chem. 2011, 286, 3693-3706
14. Ono, K.; Condron, M. M.; Teplow, D. B. Structure-Neurotoxicity Relationships of Amyloid Beta-Protein Oligomers Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 14745-14750
15. Hartley, D. M.; Walsh, D. M.; Ye, C. P.; Diehl, T.; Vasquez, S.; Vassilev, P. M.; Teplow, D. B.; Selkoe, D. J. Protofibrillar Intermediates of Amyloid Beta-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons J. Neurosci. 1999, 19, 8876-8884
16. Zhang, Y.; McLaughlin, R.; Goodyer, C.; LeBlanc, A. Selective Cytotoxicity of Intracellular Amyloid Beta Peptide1-42 through P53 and Bax in Cultured Primary Human Neurons J. Cell. Biol. 2002, 156, 519-529
17. Citron, M. Alzheimer's Disease: Strategies for Disease Modification Nat. Rev. Drug Discovery 2010, 9, 387-398
18. Weiner, H. L.; Frenkel, D. Immunology and Immunotherapy of Alzheimer's Disease Nat. Rev. Immunol. 2006, 6, 490
19. De Strooper, B. Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process Physiol. Rev. 2010, 90, 465-494
20. Hamley, I. W. The Amyloid Beta Peptide: A Chemist's Perspective. Role in Alzheimer's and Fibrillization Chem. Rev. 2012, 5147-5192
21. Serpell, L. C.; Blake, C. C.; Fraser, P. E. Molecular Structure of a Fibrillar Alzheimer's A beta Fragment Biochemistry 2000, 39, 13269-13275
22. Selkoe, D. J.; Schenk, D. Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics Annu. Rev. Pharmacol. Toxicol. 2003, 43, 545-584
23. Teplow, D. B. Structural and Kinetic Features of Amyloid Beta-Protein Fibrillogenesis Amyloid 1998, 5, 121-142
24. Shirotani, K.; Tsubuki, S.; Iwata, N.; Takaki, Y.; Harigaya, W.; Maruyama, K.; Kiryu-Seo, S.; Kiyama, H.; Iwata, H.; Tomita, T.; Iwatsubo, T.; Saido, T. C. Neprilysin Degrades Both Amyloid Beta Peptides 1-40 and 1-42 Most Rapidly and Efficiently among Thiorphan- and Phosphoramidon-Sensitive Endopeptidases J. Biol. Chem. 2001, 276, 21895-21901
25. Miners, J. S.; Baig, S.; Palmer, J.; Palmer, L. E.; Kehoe, P. G.; Love, S. A Beta-Degrading Enzymes in Alzheimer's Disease Brain Pathol. 2008, 18, 240-252
26. Iwata, N.; Tsubuki, S.; Takaki, Y.; Shirotani, K.; Lu, B.; Gerard, N. P.; Gerard, C.; Hama, E.; Lee, H. J.; Saido, T. C. Metabolic Regulation of Brain a Beta by Neprilysin Science 2001, 292, 1550-1552
27. Iwata, N.; Tsubuki, S.; Takaki, Y.; Watanabe, K.; Sekiguchi, M.; Hosoki, E.; Kawashima-Morishima, M.; Lee, H. J.; Hama, E.; Sekine-Aizawa, Y.; Saido, T. C. Identification of the Major Abeta(1-42)-Degrading Catabolic Pathway in Brain Parenchyma: Suppression Leads to Biochemical and Pathological Deposition Nat. Med. 2000, 6, 143-150
28. Iwata, N.; Mizukami, H.; Shirotani, K.; Takaki, Y.; Muramatsu, S.; Lu, B.; Gerard, N. P.; Gerard, C.; Ozawa, K.; Saido, T. C. Presynaptic Localization of Neprilysin Contributes to Efficient Clearance of Amyloid-Beta Peptide in Mouse Brain J. Neurosci. 2004, 24, 991-998
29. El-Amouri, S. S.; Zhu, H.; Yu, J.; Marr, R.; Verma, I. M.; Kindy, M. S. Neprilysin: An Enzyme Candidate to Slow the Progression of Alzheimer's Disease Am. J. Pathol. 2008, 172, 1342-1354
30. Tampellini, D.; Rahman, N.; Lin, M. T.; Capetillo-Zarate, E.; Gouras, G. K. Impaired Beta-Amyloid Secretion in Alzheimer's Disease Pathogenesis J. Neurosci. 2011, 31, 15384-15390
31. Marr, R. A.; Guan, H.; Rockenstein, E.; Kindy, M.; Gage, F. H.; Verma, I.; Masliah, E.; Hersh, L. B. Neprilysin Regulates Amyloid Beta Peptide Levels J. Mol. Neurosci. 2004, 22, 5-11
32. Hemming, M. L.; Patterson, M.; Reske-Nielsen, C.; Lin, L.; Isacson, O.; Selkoe, D. J. Reducing Amyloid Plaque Burden Via Ex Vivo Gene Delivery of an a Beta-Degrading Protease: A Novel Therapeutic Approach to Alzheimer Disease PLoS Med. 2007, 4, 1405-1416
33. Li, Y.; Wang, J.; Liu, J.; Liu, F. A Novel System for in Vivo Neprilysin Gene Delivery Using a Syringe Electrode J. Neurosci. Methods 2010, 193, 226-231
34. Guan, H.; Liu, Y.; Daily, A.; Police, S.; Kim, M.-H.; Oddo, S.; LaFerla, F. M.; Pauly, J. R.; Murphy, M. P.; Hersh, L. B. Peripherally Expressed Neprilysin Reduces Brain Amyloid Burden: A Novel Approach for Treating Alzheimer's Disease J. Neurosci. Res. 2009, 87, 1462-1473
35. Liu, Y.; Studzinski, C.; Beckett, T.; Guan, H.; Hersh, M. A.; Murphy, M. P.; Klein, R.; Hersh, L. B. Expression of Neprilysin in Skeletal Muscle Reduces Amyloid Burden in a Transgenic Mouse Model of Alzheimer Disease Mol. Ther. 2009, 17, 1381-1386
36. Liu, Y.; Studzinski, C.; Beckett, T.; Murphy, M. P.; Klein, R. L.; Hersh, L. B. Circulating Neprilysin Clears Brain Amyloid Mol. Cell. Neurosci. 2010, 45, 101-107
37. Spencer, B.; Marr, R. A.; Gindi, R.; Potkar, R.; Michael, S.; Adame, A.; Rockenstein, E.; Verma, I. M.; Masliah, E. Peripheral Delivery of a CNS Targeted, Metalo-Protease Reduces Ab Toxicity in a Mouse Model of Alzheimer's Disease PLoS One 2011, 6, 1-12
38. Iijima-Ando, K.; Hearn, S. A.; Granger, L.; Shenton, C.; Gatt, A.; Chiang, H. C.; Hakker, I.; Zhong, Y.; Iijima, K. Overexpression of Neprilysin Reduces Alzheimer Amyloid-Beta 42 (Abeta 42)-Induced Neuron Loss and Intraneuronal Abeta 42 Deposits but Causes a Reduction in Camp-Responsive Element-Binding Protein-Mediated Transcription, Age-Dependent Axon Pathology, and Premature Death in Drosophila J. Biol. Chem. 2008, 283, 19066-19076
39. Aharoni, A.; Gaidukov, L.; Khersonsky, O.; Gould, S. M.; Roodveldt, C.; Tawfik, D. S. The 'Evolvability' of Promiscuous Protein Functions Nat. Genet. 2005, 37, 73-76
40. Sexton, T.; Hitchcook, L. J.; Rodgers, D. W.; Bradley, L. H.; Hersh, L. B. Active Site Mutations Change the Cleavage Specificity of Neprilysin PLoS One 2012, 7, e32343
41. Oefner, C.; Roques, B. P.; Fournie-Zaluski, M. C.; Dale, G. E. Structural Analysis of Neprilysin with Various Specific and Potent Inhibitors Acta Crystallogr., Sect. D: Biol. Crystallogr. 2004, 60, 392-396
42. Oefner, C.; D'Arcy, A.; Hennig, M.; Winkler, F. K.; Dale, G. E. Structure of Human Neutral Endopeptidase (Neprilysin) Complexed with Phosphoramidon J. Mol. Biol. 2000, 296, 341-349
43. Oefner, C.; Pierau, S.; Schulz, H.; Dale, G. E. Structural Studies of a Bifunctional Inhibitor of Neprilysin and Dpp-Iv Acta Crystallogr. Sect. D: Biol. Crystallogr. 2007, 63, 975-981
44. Dale, G. E.; Oefner, C. Neprilysin. In Handbook of Metalloproteins; John Wiley & Sons, Ltd.: Chichester, West-Sussex, United Kingdom, 2006; pp 1-12.
45. Glossop, M. S.; Bazin, R. J.; Dack, K. N.; Fox, D. N.; MacDonald, G. A.; Mills, M.; Owen, D. R.; Phillips, C.; Reeves, K. A.; Ringer, T. J.; Strang, R. S.; Watson, C. A. Synthesis and Evaluation of Heteroarylalanine Diacids as Potent and Selective Neutral Endopeptidase Inhibitors Bioorg. Med. Chem. Lett. 2011, 21, 3404-3406
46. Sahli, S.; Frank, B.; Schweizer, W. B.; Diederich, F.; Blum-Kaelin, D.; Aebi, J. D.; Böhm, H.-J.; Oefner, C.; Dale, G. E. Second-Generation Inhibitors for the Metalloprotease Neprilysin Based on Bicyclic Heteroaromatic Scaffolds: Synthesis, Biological Activity, and X-Ray Crystal-Structure Analysis Helv. Chim. Acta 2005, 88, 731-750
47. Gomez-Monterrey, I.; Turcaud, S.; Lucas, E.; Bruetschy, L.; Roques, B. P.; Fournie-Zaluski, M. C. Exploration of Neutral Endopeptidase Active Site by a Series of New Thiol-Containing Inhibitors J. Med. Chem. 1993, 36, 87-94
48. Schechter, I.; Berger, A. On the Size of the Active Site in Proteases. I. Papain Biochem. Biophys. Res. Commun. 1967, 27, 157-162
49. Pope, D.; Cascio, M. Neprilysin Inhibitors Provide Insight into Its Specificity and Therapeutic Potential. In Frontiers in Drug Design & Discovery, 6 ed.; Atta-ur-Rahman; Choudhary, M. I., Eds.; Bentham Science Publishers: Sharjah, United Arab Emirates, 2014; Vol. 6, pp 353-377.
50. Manzetti, S. Computer Modeling and Nanosecond Simulation of the Enzyme-Substrate Complex of the Common Lymphoblastic Leukemia Antigen (Neprilysin) Indicates Shared Residues at the Primary Specificity Pocket (S1′) with Matrix Metalloproteases J. Mol. Model. 2003, 9, 348-354
51. Dimitropoulos, N.; Papakyriakou, A.; Dalkas, G. A.; Sturrock, E. D.; Spyroulias, G. A. A Computational Approach to the Study of the Binding Mode of Dual ACE/NEP Inhibitors J. Chem. Inf. Model. 2010, 50, 388-396
52. Molecular Operating Environment (MOE), 2011.10; Chemical Computing Group, Inc.: Montreal, QC, Canada, 2011.
53. Corbeil, C. R.; Williams, C. I.; Labute, P. Variability in Docking Success Rates Due to Dataset Preparation J. Comput.-Aided Mol. Des. 2012, 26, 775-786
54. Mikulskis, P.; Genheden, S.; Rydberg, P.; Sandberg, L.; Olsen, L.; Ryde, U. Binding Affinities in the Sampl3 Trypsin and Host-Guest Blind Tests Estimated with the Mm/Pbsa and Lie Methods J. Comput.-Aided Mol. Des. 2012, 26, 527-541
55. Kollman, P. A.; Massova, I.; Reyes, C.; Kuhn, B.; Huo, S.; Chong, L.; Lee, M.; Lee, T.; Duan, Y.; Wang, W.; Donini, O.; Cieplak, P.; Srinivasan, J.; Case, D. A.; Cheatham, T. E., 3rd. Calculating Structures and Free Energies of Complex Molecules: Combining Molecular Mechanics and Continuum Models Acc. Chem. Res. 2000, 33, 889-897
56. Crescenzi, O.; Tomaselli, S.; Guerrini, R.; Salvadori, S.; D'Ursi, A. M.; Temussi, P. A.; Picone, D. Solution Structure of the Alzheimer Amyloid Beta-Peptide (1-42) in an Apolar Microenvironment. Similarity with a Virus Fusion Domain Eur. J. Biochem. 2002, 269, 5642-5648
57. Bayly, C.; Mckay, D.; Truchon, J.-F. An Informal Amber Small Molecule Force Field: Parm@Frosst, 2010. CCL.net. http://www.ccl.net/cca/data/parm-at- Frosst/ (accessed April 12, 2012).
58. Jakalian, A.; Jack, D. B.; Bayly, C. I. Fast, Efficient Generation of High-Quality Atomic Charges. AM1-BCC Model: II. Parameterization and Validation J. Comput. Chem. 2002, 23, 1623-1641
59. Chen, H.; Noble, F.; Mothe, A.; Meudal, H.; Coric, P.; Danascimento, S.; Roques, B. P.; George, P.; Fournie-Zaluski, M. C. Phosphinic Derivatives as New Dual Enkephalin-Degrading Enzyme Inhibitors: Synthesis, Biological Properties, and Antinociceptive Activities J. Med. Chem. 2000, 43, 1398-1408
60. Marie-Claire, C.; Ruffet, E.; Antonczak, S.; Beaumont, A.; O'Donohue, M.; Roques, B. P.; Fournie-Zaluski, M. C. Evidence by Site-Directed Mutagenesis that Arginine 203 of Thermolysin and Arginine 717 of Neprilysin (Neutral Endopeptidase) Play Equivalent Critical Roles in Substrate Hydrolysis and Inhibitor Binding Biochemistry 1997, 36, 13938-13945
61. Fournie-Zaluski, M. C.; Gonzalez, W.; Turcaud, S.; Pham, I.; Roques, B. P.; Michel, J. B. Dual Inhibition of Angiotensin-Converting Enzyme and Neutral Endopeptidase by the Orally Active Inhibitor Mixanpril: A Potential Therapeutic Approach in Hypertension Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 4072-4076
62. Fournie-Zaluski, M. C.; Lucas, E.; Waksman, G.; Roques, B. P. Differences in the Structural Requirements for Selective Interaction with Neutral Metalloendopeptidase (Enkephalinase) or Angiotensin-Converting Enzyme. Molecular Investigation by Use of New Thiol Inhibitors Eur. J. Biochem. 1984, 139, 267-274
63. Fink, C. A.; Qiao, Y.; Berry, C. J.; Sakane, Y.; Ghai, R. D.; Trapani, A. J. New Alpha-Thiol Dipeptide Dual Inhibitors of Angiotensin-I Converting Enzyme and Neutral Endopeptidase EC 3.4.24.11 J. Med. Chem. 1995, 38, 5023-5030
64. Roderick, S. L.; Fournie-Zaluski, M. C.; Roques, B. P.; Matthews, B. W. Thiorphan and Retro-Thiorphan Display Equivalent Interactions When Bound to Crystalline Thermolysin Biochemistry 1989, 28, 1493-1497
65. Dion, N.; Le Moual, H.; Fournie-Zaluski, M. C.; Roques, B. P.; Crine, P.; Boileau, G. Evidence That Asn542 of Neprilysin (EC 3.4.24.11) is Involved in Binding of the P2′ Residue of Substrates and Inhibitors Biochem. J. 1995, 311, 623-627
66. Tiraboschi, G.; Jullian, N.; Thery, V.; Antonczak, S.; Fournie-Zaluski, M. C.; Roques, B. P. A Three-Dimensional Construction of the Active Site (Region 507-749) of Human Neutral Endopeptidase (EC.3.4.24.11) Protein Eng. 1999, 12, 141-149
67. Leissring, M. A.; Lu, A.; Condron, M. M.; Teplow, D. B.; Stein, R. L.; Farris, W.; Selkoe, D. J. Kinetics of Amyloid Beta-Protein Degradation Determined by Novel Fluorescence- and Fluorescence Polarization-Based Assays J. Biol. Chem. 2003, 278, 37314-37320
68. Howell, S.; Nalbantoglu, J.; Crine, P. Neutral Endopeptidase Can Hydrolyze Beta-Amyloid(1-40) but Shows No Effect on Beta-Amyloid Precursor Protein Metabolism Peptides 1995, 16, 647-652
69. Tsubuki, S.; Takaki, Y.; Saido, T. C. Dutch, Flemish, Italian, and Arctic Mutations of APP and Resistance of Abeta to Physiologically Relevant Proteolytic Degradation Lancet 2003, 361, 1957-1958
70. Betts, V.; Leissring, M. A.; Dolios, G.; Wang, R.; Selkoe, D. J.; Walsh, D. M. Aggregation and Catabolism of Disease-Associated Intra-Abeta Mutations: Reduced Proteolysis of Abeta(A21G) by Neprilysin Neurobiol. Dis. 2008, 31, 442-450
71. Hersh, L. B.; Rodgers, D. W. Neprilysin and Amyloid Beta Peptide Degradation Curr. Alzheimer Res. 2008, 5, 225-231
72. Kim, Y. A.; Shriver, B.; Quay, T.; Hersh, L. B. Analysis of the Importance of Arginine 102 in Neutral Endopeptidase (Enkephalinase) Catalysis J. Biol. Chem. 1992, 267, 12330-12335
73. Liao, M. Q.; Tzeng, Y. J.; Chang, L. Y.; Huang, H. B.; Lin, T. H.; Chyan, C. L.; Chen, Y. C. The Correlation between Neurotoxicity, Aggregative Ability and Secondary Structure Studied by Sequence Truncated Abeta Peptides FEBS Lett. 2007, 581, 1161-1165
74. Liu, R.; McAllister, C.; Lyubchenko, Y.; Sierks, M. R. Residues 17-20 and 30-35 of Beta-Amyloid Play Critical Roles in Aggregation J. Neurosci. Res. 2004, 75, 162-171
75. Mukherjee, A.; Song, E.; Kihiko-Ehmann, M.; Goodman, J. P., Jr.; Pyrek, J. S.; Estus, S.; Hersh, L. B. Insulysin Hydrolyzes Amyloid Beta Peptides to Products that are Neither Neurotoxic nor Deposit on Amyloid Plaques J. Neurosci. 2000, 20, 8745-8749